Help | RSS Feed



Female Health (NASD:FHCO) Seasonal Chart

Female Health (NASD:FHCO) Seasonality

FHCO Relative to the S&P 500
FHCO Relative to the S&P 500

FHCO Relative to the Sector
FHCO Relative to the Sector

Monthly Seasonal Female Health (NASD:FHCO)

Seasonal Chart Analysis

Analysis of the Female Health (NASD:FHCO) seasonal charts above shows that a Buy Date of November 16 and a Sell Date of March 1 has resulted in a geometric average return of 11.41% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 16.46% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Consumer Staples sector, which runs from April 25 to November 23. The seasonal chart for the broad sector is available via the following link: Consumer Staples Sector Seasonal Chart.

The Female Health Co is a pharmaceutical and medical device company. The company is focus on
the development and commercialization of pharmaceuticals that qualify for the
Food and Drug Administration’s 505(b)(2) and 505(b)(1) regulatory approval
pathway.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore